|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 57.55M 4.45M 4.16M 3.81M 7.15M 497M 7.25M 49.21M 19.19M 250M 19.51M 19.09M 826M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 116M 8.95M 8.37M 7.66M 14.38M 999M 14.57M 98.92M 38.58M 502M 39.22M 38.37M 1.66B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -1.41% | +4.90% | +78.50% | +126.49% | 1,119B | |
| +0.19% | +3.41% | +52.07% | +64.34% | 651B | |
| -0.57% | +5.56% | +27.31% | +80.21% | 468B | |
| -1.52% | +3.93% | +42.40% | +42.26% | 374B | |
| -0.57% | +2.71% | +25.19% | +41.04% | 302B | |
| -1.45% | +4.34% | +1.60% | +12.20% | 259B | |
| +0.35% | +4.95% | +52.58% | +71.52% | 238B | |
| -0.43% | +2.60% | -18.32% | -53.55% | 208B | |
| -0.64% | +4.90% | +27.67% | +90.92% | 181B | |
| Average | -0.70% | +5.17% | +32.11% | +52.83% | 379.99B | |
| Weighted average by Cap. | -0.81% | +5.40% | +45.30% | +72.29% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 98.49M 7.62M 7.13M 6.52M 12.24M 851M 12.41M 84.21M 32.84M 427M 33.39M 32.66M 1.41B | 9.91M 110M 8.49M 7.94M 7.27M 13.64M 948M 13.82M 93.84M 36.59M 476M 37.21M 36.4M 1.58B |
| Net income | 665K 7.37M 570K 533K 488K 916K 63.63M 928K 6.3M 2.46M 31.96M 2.5M 2.44M 106M | 762K 8.43M 652K 610K 559K 1.05M 72.86M 1.06M 7.21M 2.81M 36.6M 2.86M 2.8M 121M |
| Net Debt | 4.15M 45.93M 3.55M 3.32M 3.04M 5.71M 397M 5.79M 39.27M 15.31M 199M 15.57M 15.23M 659M | 5.25M 58.14M 4.5M 4.21M 3.85M 7.23M 502M 7.32M 49.71M 19.39M 252M 19.71M 19.28M 835M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
